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ABSTRACT 
The post-meiotic phase of mouse spermatogenesis (spermiogenesis) is very sensitive to 
the genomic effects of environmental mutagens because as male germ cells form mature sperm 
they progressively lose the ability to repair DNA damage. We hypothesized that repeated 
exposures to mutagens during this repair-deficient phase result in the accumulation of heritable 
genomic damage in mouse sperm that leads to chromosomal aberrations in zygotes after 
fertilization. We used a combination of single or fractionated exposures to diepoxybutane (DEB), 
a component of tobacco smoke, to investigate how differential DNA repair efficiencies during 
the three weeks of spermiogenesis affected the accumulation of DEB-induced heritable damage 
in early spermatids (21-15 days before fertilization, dbf), late spermatids (14-8 dbf) and sperm 
(7- 1 dbf). Analysis of chromosomal aberrations in zygotic metaphases using PAINT/DAPI 
showed that late spermatids and sperm are unable to repair DEB-induced DNA damage as 
demonstrated by significant increases (P<0.001) in the frequencies of zygotes with chromosomal 
aberrations. Comparisons between single and fractionated exposures suggested that the DNA 
repair-deficient window during late spermiogenesis may be less than two weeks in the mouse 
and that during this repair-deficient window there is accumulation of DNA damage in sperm. 
Finally, the dose-response study in sperm indicated a linear response for both single and repeated 
exposures. These findings show that the differential DNA repair capacity of post-meioitic male 
germ cells has a major impact on the risk of paternally transmitted heritable damage and suggest 
that chronic exposures that may occur in the weeks prior to fertilization because of occupational 
or lifestyle factors (i.e, smoking) can lead to an accumulation of genetic damage in sperm and 
result in heritable chromosomal aberrations of paternal origin.  
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INTRODUCTION 
Spermatogenesis is a complex differentiating system that is initiated from stem cells 
through division of spermatogonia to form spermatocytes (meiotic cells), which after two 
meiotic divisions give rise to haploid spermatids (postmeiotic cells) [1]. During the last phase of 
spermatogenesis, also known as spermiogenesis, haploid spermatids undergo major 
morphological changes to form mature spermatozoa [2, 3].  The somatic and meiotic histones of 
spermatids are replaced ~14 days before ejaculation in the mouse (~21 days in humans) with 
basic transition proteins [4] and then with protamines, which are arginine-rich proteins that 
condense the chromatin to a level that is 6 times more compacted than that observed in mitotic 
chromosomes [5] and causes the DNA to become transcriptionally inactive and inaccessible to 
DNA repair proteins [6]. The process requires a profound change in DNA topology that involves 
the introduction of many single and double strand breaks to eliminate negative supercoiling [2, 
7]. Transition proteins are thought to play an important role in assuring the proper repair of these 
breaks by bringing broken DNA fragments into close proximity [5] and there is evidence that 
they can stimulate DNA repair following genotoxic insults and contribute to maintaining the 
integrity of the male genome [5, 8-10]. 
It is well established that postmeiotic male germ cells are extremely sensitive to the 
induction of heritable genomic damage. Over fifty years of germ cell mutagenesis have shown 
that the majority of mutagens induce their highest effect during the last few weeks of 
spermatogenesis before fertilization [11, 12]. The high sensitivity of the postmeiotic period to 
mutagenic exposure has been associated with the reduced DNA repair capacity of late spermatids 
and sperm as compared to early spermatids and other spermatogenic cell types [13-17]. All 
major DNA repair pathways seem to be less functional in late spermatids and sperm [17-20]. 
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This inability of sperm to repair DNA lesions as they occur may make them particularly 
susceptible to repeated exposures that take place because of occupational or life style (e.g. 
tobacco smoking) reasons. These observations suggest that genomic damage induced in late 
spermatids and sperm may accumulate in the fertilizing sperm and be transmitted to the embryo. 
The analysis of paternal chromosomes at the metaphase plate of the first-cleavage 
division (1-Cl) provides the earliest time after fertilization where paternal chromosomes can be 
investigated by classic cytogenetic methods [12, 21]. At least 16 male germ cell mutagens have 
been shown to increase chromosomal aberrations in mouse zygotes after exposure of postmeiotic 
male germ cells [12]. These mutagens have a variety of mechanisms of actions, including DNA 
alkylation, protein alkylation, and DNA cross-linking, yet, they all produced almost exclusively 
chromosome-type aberrations, i.e., affecting both sister chromatids, at 1-Cl metaphase. Although 
it is still unclear why this is the case, these consistent observations of chromosome-type 
aberrations prove that double strand breaks (DSBs) are an obligatory step in the processing of 
sperm lesions into chromosomal aberrations at 1-Cl metaphase. It was postulated that protamine 
adducts may be the primary type of damage induced in postmeiotic cells by alkylating agents and 
that adducted protamines create physical stresses in the chromatin structure leading to DSBs 
before fertilization [22]. Alternatively, adducted protamines may be refractory to removal from 
DNA during pronuclear formation in the fertilized egg, and thus may indirectly function as 
“bulky DNA adducts”. Other lesions, such as single strand breaks, base damages and apurinic or 
apyramidinic sites could be converted into DSBs by misrepair before zygotic S-phase leading 
chromosome-type aberrations at 1-Cl metaphase [23]. Studies with DNA repair inhibitors in 
mouse zygotes after sperm treatment with X-rays and chemical agents have provided compelling 
evidence that chromosomal aberrations were formed after fertilization rather than before [23-25]. 
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Finally, we recently obtained strong evidence that DSBs persisted unrepaired in the sperm for at 
least 7 days before fertilization and that improper repair of transmitted DSBs by the egg leads to 
increases frequencies of zygotes with aberrations in paternal chromosomes at 1-Cl metaphase 
[26].  
Substantial evidence indicates that tobacco smoking by either parent is associated with 
increased risk of abnormal pregnancy outcomes. However, little is known of the mechanisms by 
which tobacco smoking may damage germ cells and affect the developing embryo. Tobacco 
smoke contains numerous carcinogenic, mutagenic, and reproductive toxicants [27-30]. 1,3-
butadiene (BD) is one of the few constituents of tobacco smoke tested for heritable and 
developmental effects in laboratory animals [31-34]. BD is classified as a probable human 
carcinogen [35] and is present in mainstream tobacco smoke at a concentration of 16-75 
µg/cigarette and at higher concentrations (205-361 µg/cigarette) in sidestream smoke [36], the 
main constituent of environmental tobacco smoke or second-hand smoke. BD has marked 
species differences in susceptibility to the carcinogenic effect, possibly due to differences in 
metabolism [37-40]. BD is metabolized by the cytochrome P-450-dependent monoxygenases to 
1,2-epoxybutene-3 (EB), which is further metabolized by oxidation to diepoxybutane (DEB) [39-
41]. DEB is a bifunctional alkylating agent that induces interstrand and intrastrand DNA-DNA 
crosslinks by alkylating two adjacent bases within the major grove of a DNA duplex [42, 43] and 
DNA-protein crosslinks [44-46]. DEB is both a somatic and germ cell mutagen in mammals [47-
49]. Exposure of male rodents to DEB induces cytogenetic damage in meiotic cells [50] and in 
zygotes [50, 51], as well as dominant lethality and heritable translocations in the offspring [51]. 
The specific goals of this study were to determine: i) whether the ability of repairing 
DEB-induced DNA damage declines as male germ cells progress through spermiogenesis; ii) 
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whether DEB-induced sperm lesions accumulate during spermiogenesis; iii) the effective 
duration of the DNA repair-deficient phase of spermiogenesis after DEB exposure; and, iv) the 
dose-response curve for the induction of chromosomal aberrations in zygotes after either single 
or fractionated DEB exposure of male germ cells.   
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MATERIAL AND METHODS 
Animals and treatments 
 The use of vertebrate animals in these experiments was approved by both the Lawrence 
Livermore National Laboratory and Lawrence Berkeley National Laboratory Institutional 
Animal Care and Use Committees.  B6C3F1 mice (Harlan Sprague-Dawley Inc., Indianapolis, 
IN, USA) between 8 and 12 weeks of age were maintained under a 12 hr light/12 hr dark 
photoperiod (light from 7.00 am to 7:00 pm) at room temperature of 21-23° C and relative 
humidity of 50 ± 5%. Food and water were provided ad libitum. Male mice were randomly 
assigned to treated and control experimental groups.  
All experimental treatment regimens are shown in Figure 1. The highest acute DEB dose 
utilized in this study was selected based on published data [51] and initial experiments in which 
mice were treated with a dose of 42 mg/kg DEB (CAS No. 1464-53-5, Sigma) and mated with 
untreated females seven days later. This DEB dose produced severe morbidity as demonstrated 
by a significant reduction in the percentages of males that mated (30% vs 80% in controls), 
therefore, its use was discontinued. DEB was dissolved in PBS and administered 
intraperitoneally (i.p.) at the final volume of 0.01 ml/g body weight. For fractionated exposure 
studies, males received daily doses of 4 mg/kg DEB for 1, 2, or 3 weeks before mating and 
allowed to mate 0, 7 or 14 days after the end of treatment (experiments 9 through 14 in Fig. 1). 
To compare fractionated vs. single exposures, males were treated with 28 mg/kg DEB and 
allowed to mate with untreated females 7, 14 or 21 days later (experiments 6, 7 and 8 in Fig. 1). 
Finally, for the dose-response studies, male mice were treated with 2, 3, or 4 mg/kg DEB for 
seven days and allowed to mate with untreated females on the day of the last injection 
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(experiments, 2, 4 and 9 in Fig. 1) or to 14, 21 and 28 mg/kg DEB administered acutely seven 
days before mating (experiments 3, 5 and 6 in Fig. 1).   
 
Preparation of zygotic metaphases and FISH 
 Female mice received an i.p. injection of 7.5 I.U. of pregnant mare's serum (PMS, Sigma 
Chemical Co., St. Louis. MO, USA) to increase the number of maturing ovarian follicles, 
followed 48 hr later by an i.p. injection of 5.0 I.U. of human chorionic gonadotrophin (hCG, 
Sigma Co.) to induce ovulation. After the hCG injection, females were caged with males (1:1) 
and checked for vaginal plugs 8 hr later. Mated females received an i.p. injection of 0.08 mg/kg 
colchicine (CAS No. 64-86-8, Sigma Co.) dissolved in 0.2 ml of distilled water 24 hr after HCG 
to prevent the union of the two parental pronuclei and arrest zygotic development at the 
metaphase stage of the first cleavage division [21]. Mated females were euthanized by CO2 
inhalation 6 hr after colchicine injection, zygotes were flushed out from isolated oviducts and 
processed according to the mass harvest procedure [52]. The prepared slides were air-dried for at 
least 24 hr at room temperature, then kept in nitrogen atmosphere at -20°C until hybridization.   
First-cleavage (1-Cl) metaphases were hybridized with a probe mixture containing ten 
DNA composite painting probes: five biotin-labeled probes, each specific for chromosomes 1, 3, 
5, X or Y and five FITC-labeled probes, each specific for chromosomes 2, 4, 6, X or Y 
(CAMBIO. Cambridge, UK). Amplification of the signals was obtained using the CAMBIO 
Dual Color Painting Kit (Biotin-Texas Red and FITC) as previously described [53]. A Zeiss 
Axioplan2 fluorescent photomicroscope was used for cytogenetic analysis. The microscope was 
equipped with a double-bandpass excitor (81P102, Chroma Technology, Brattleboro, VT) for 
visualizing the red (Texas red) and green (FITC) signals; a triple-bandpass filter set (61002, 
Chroma Technology) for the simultaneous detection of the red, green, and blue (DAPI) signals; 
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and another DAPI filter set (487901, Zeiss) for visualizing DAPI fluorescence only. Images of 
normal and aberrant metaphases were captured using the CytoVisionTM Imaging Analysis 
System (Applied Image Biosystems Inc., Santa Clara, CA) and assembled using the Adobe 
Photoshop 5.0 software (Adobe System Incorporated, San Jose, CA). Metaphase analysis and 
scoring was done as previously described [53, 54]. 
 
Statistical analysis 
For each experimental group, three-four independent matings each using 12 males and 12 
females were used. The data from the three-four repetitions were pooled and the mean plus the 
standard error of the mean was calculated for all the endpoints measured. A chi-square was 
performed to assure that the observations within each group followed a Poisson distribution. If 
this was not the case, a chi-square with adjustment for overdispersion [55] was used to test for 
differences in the various endpoints between controls and treated groups.  
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RESULTS 
A total of 13 regimens of single or fractionated exposures to DEB plus controls (Figure 
1) were used to investigate how the differential abilities of early spermatids, late spermatids and 
sperm to repair DEB-induced damage affected the accumulation of DNA damage in male germ 
cells and its transmission to the zygote. As shown in Figure 1, the duration between the end of 
DEB exposure and fertilization was used to assess the relative sensitivities of sperm (7-1 days 
before fertilization, bdf), late spermatids (14-8 dbf) and early spermatids (21-15 dbf) to the 
induction of heritable DNA damage as detected using PAINT/DAPI analysis of chromosomal 
aberrations at first metaphase after fertilization [53, 54, 56, 57].  
 
Chromosomal aberrations detected in zygotes after repeated exposures of male germ cells to 
DEB 
The cytogenetic results for single and fractionated DEB exposures are shown in Table 1. 
Seven daily exposures of 4 mg/kg DEB significantly increased the frequencies of zygotes with 
chromosomal aberrations when sperm and late spermatids were treated (p<0.001; Experiments 9 
and 10) but not when round spermatids were exposed (Experiment 11). These results show that 
the last two weeks of mouse spermiogenesis, which corresponds to the period of spermatogenesis 
that is thought to be DNA repair-deficient in prior studies [13-20], is also the sensitive window 
for induction of chromosomal aberrations in sperm after paternal exposure to DEB, and that both 
sperm and late spermatids are unable to repair DEB-induced damage.  
To determine whether there was accumulation of heritable DNA damage in sperm, the 
results of the one-week exposures (experiments 9, 10 and 11) were used to predict the 
frequencies of zygotes with chromosomal aberrations that would be expected in the multi-week 
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exposures (experiments 12, 13 and 14). For example, experiments 9 and 10 together covered the 
same window of spermiogenesis as experiment 12. Based on the results of experiments 9 and 10 
(Table 1), we expected that 20% (11.8 plus 9.2) of the zygotes would have chromosomal 
aberrations in experiment 12. The observed frequency of zygotes with chromosomal aberrations 
in experiment 12 (16.7%) was not different for the expected (P=0.3). Similarly, the frequencies 
of zygotes with chromosomal aberrations in experiments 13 (8.7%) and 14 (16.4%) were not 
different (P=0.5 and P=0.2, respectively) from those expected (10.3% and 21.1%) based on the 
results of the one-week exposures that covered the same window of spermiogenesis, 
(experiments 10 plus 11 for experiment 13; experiments 9 plus 10 plus 11 for experiment 14). 
The concordance between the estimates of zygotes with chromosomal aberrations based on the 
one-week exposures (experiments 9, 10 and 11, Table 1) and those observed in multi-week 
exposures (experiments 12, 13 and 14, Table 1) suggest that DEB-induced heritable damage 
accumulates in late spermatids and sperm. 
 
Identification of the DNA repair-deficient window of mouse spermiogenesis  
To investigate the efficiency of repairing DEB-induced heritable damage during the three 
weeks of spermiogenesis, we compared the results among the experiments in which the same 
dose of DEB was given either as a single daily dose or fractionated over seven days (Table 1 and 
Figure 3). Administration of 28 mg/kg DEB as seven daily doses of 4 mg/kg each during the last 
week before mating (experiment 9) or as a single dose seven days before mating (experiment 6) 
produced similar frequencies of zygotes with chromosomal aberrations (11.8 vs. 9.7%; P=0.4). 
This suggests that there was no detectable repair of DEB lesions during the last week before 
mating and that DEB-induced damage accumulated during this time. However, when 28 mg/kg 
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DEB was given as a single dose 14 days before mating (experiment 7), the frequency of zygotes 
with chromosomal aberrations was significantly lower than that found when DEB was 
administered over 7 days (experiment 10; 4.2 vs. 9.2%, P<0.05; Figure 3A), but still higher than 
control values (P<0.01). This indicates that some repair occurred for lesions induced on day 14 
before mating. Administration of 28 mg/kg DEB 21 days before fertilization (experiment 8) did 
not increase the frequency of zygotes with chromosomal aberrations with respect to the 
spontaneous frequency as it was observed after repeated exposures of early spermatids 
(experiment 11). Collectively, these results indicates that early spermatids are fully competent to 
repair DEB-induced lesions, that late spermatids become less proficient in lesion repair with 
some DNA repair still occurring on day 14 before mating, and that sperm are completely repair 
deficient and prone to accumulation of heritable DNA damage.   
 
Shape of the dose-response curve after single or repeated exposures to DEB 
To characterize the shape of the dose-response curve for the induction of germ cell 
lesions that lead to heritable chromosomal aberrations during the most sensitive window of 
spermiogenesis, male mice were treated with seven daily injections of 2, 3 or 4 mg/kg DEB 
(experiments 2, 4 and 9) and mated to untreated females immediately after the last injection 
(fractionated exposures). For single exposures, male mice were treated with 14, 21 or 28 mg/kg 
DEB (experiments 3, 5 and 6) and mated to untreated females seven days later. The results of the 
dose-response study showed a linear-dose response (r2=0.95; Figure 3B) and that the frequencies 
of zygotes with chromosomal aberrations were dependent on the DEB dose but not on whether it 
was given as a single dose or fractionated over seven days. The increases (P>0.1) in the 
frequencies of zygotes with chromosomal aberrations after treatment with 14 mg/kg DEB as a 
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single dose or over seven days before mating did not reach statistical significance because the 
number of metaphases that were analyzed did not provide enough power to detect such a small 
effect.  
These results provide further evidence that during the DNA repair-deficient period of 
spermiogenesis, there is accumulation of DNA lesions in sperm that are transmitted to the zygote 
where they originate chromosomal aberrations.   
 
Subpopulation of sperm with highly damaged chromosomes 
The analysis of zygotic metaphases using PAINT/DAPI highlighted the presence of a 
subset of zygotes with extremely high levels of cytogenetic damage in the paternal chromosomes 
(Figure 2B and Tables 1). These highly damaged paternal chromosomal complements were 
observed only in those experiments (4, 5, 6, 9, 12, and 14) that exposed male germ cells to DEB 
as sperm (i.e., during the last week before mating) and represented about 2% of all metaphases 
analyzed (31/1595) and ~17% of the abnormal metaphases found (31/182). The spectrum of 
chromosomal aberrations observed in these highly damaged metaphases did not differ from that 
observed in those with less chromosomal damage. Chromosomal exchanges and acentric 
fragments represented the most common aberrations in both types of metaphases. These results 
indicate that there is a subpopulation of sperm that is particularly sensitive to the effects of DEB 
and that highly damaged sperm are able to fertilize mouse eggs and support development through 
at least the first cell cycle after fertilization. 
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DISCUSSION 
 We show that male postmeiotic germ cells differ in their abilities to repair DEB-induced 
lesions and that this has a significant impact on the amount of heritable genetic damage that is 
transmitted to the zygote and converted into chromosomal structural aberrations at 1-Cl 
metaphase. Comparisons between single and fractionated exposure regimens over the three 
weeks of mouse spermiogenesis showed that: i) the last two weeks before fertilization are the 
critical time-window for the induction of heritable lesions in sperm after paternal exposure to 
DEB; ii) heritable lesions accumulate in fertilizing sperm after exposure of late spermatids and 
sperm; and iii) the DNA repair-deficient window of mouse spermiogenesis for DEB-induced 
lesions is less than two weeks long. Our findings are consistent with a three-window model for 
the differing sensitivity of spermiogenesis to DEB-induced damage. These three-windows differ 
in their chromatin organization and DNA repair competency (Figure 4). During the repair-
proficient window (I), characterized by efficient DNA repair capacity and DNA complexed with 
histones, DEB-induced lesions are repaired by the spermatid DNA repair machinery and little 
DNA damage is transmitted to the zygote. During the transition window (II), characterized by 
declining DNA repair capacity and the replacement of histones with transition proteins and 
protamines, some lesions are not repaired and transmitted to the zygote. During the repair 
deficient window (III), characterized by the absence of DNA repair and the compaction of DNA 
by protamines, unrepaired DEB-induced lesions are transmitted to the zygote. Unrepaired sperm 
DNA lesions can be missrepaired by the egg repair machinery into chromosomal aberrations 
during G1 and become visible at 1-Cl metaphase. 
 It is well known that chromosomal defects transmitted through male and female germ 
lines are associated with a variety of abnormal reproductive outcomes [58] and that the parental 
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origin of de novo genetic and chromosomal defects is not random: e.g., autosomal aneuploidy 
has a preferential maternal origin [59], while point mutations and structural chromosomal 
rearrangements have a preferential paternal origin [60]. It has been proposed that post-meiotic 
male germ cells are susceptible to the accumulation of DNA lesions in the fertilizing sperm 
because the DNA repair capacity declines during the latter part of spermiogenesis [17]. Our 
results provide two lines of evidence in support for the accumulation of heritable lesions during 
the last two weeks of spermiogenesis: (i) the frequencies of zygotes with chromosomal 
aberrations found after exposing male mice to DEB for two or three weeks were not different 
from those expected based on the results of the one-week exposures that covered the same period 
of spermiogenesis (Table 1); (ii) DEB administration as either single dose seven days before 
mating or distributed over the last seven days immediately before mating produced similar 
frequencies of zygotes with paternally-derived chromosomal aberrations (Table 3). These results 
demonstrate that DNA lesions induced during the last phase of spermiogenesis are not repaired 
and that continuous exposure during this sensitive window results in the accumulation of 
heritable lesions. Once the sperm fertilizes the egg, these lesions generate DSBs before zygotic 
S-phase and are missrepaired into the chromosomal exchanges or acentric fragments that are 
observed at 1-Cl metaphase (Figure 1). This unique feature of male germ cell biology indicates 
that the male is particularly vulnerable to exposure to environmental mutagens during this 
sensitive window because such DNA lesions will persist unrepaired in sperm prior to fertilization 
and once in the egg have the potential to generate chromosomal aberrations which have 
detrimental effects on normal embryonic development [53]. 
Our results confirm and extend prior studies of the DNA repair-deficient window during 
spermiogenesis [13-20]. The results of our experiments showed that the frequencies of zygotes 
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with chromosomal aberrations were significantly higher when a total dose of 28 mg/kg DEB was 
given over days 14 through 8 before mating than when it was given as a single dose 14 days 
before mating (Table 2 and Figure 3A). We interpret these results as evidence that DNA repair is 
still occurring on day 14 before mating when the spermatid DNA is still complexed with 
histones, and continues during the next few days as transition proteins replace histones. The 
replacements of histones by transition proteins may provide DNA repair enzymes access to the 
damaged DNA and allows its repair. This is consistent with the observation that transition 
proteins stimulate DNA repair [8]. Overall, our results show that late spermatids lose their DNA 
repair capacity gradually over a period of several days as they complete the replacement of 
histones with transition proteins and protamines and that the window of no detectable DNA 
repair during spermiogenesis may be less than the two weeks that are currently thought.  
The inability of late spermatids and sperm to repair heritable lesions as they occur make 
these cells particularly sensitive to exposures that persist over time. This could be particularly 
important for chronic exposures that occur because of occupational or lifestyle factors (i.e., 
tobacco smoking) that may affect the genetic constitution of male germ cells in the weeks prior 
to fertilization. Indeed, several studies have reported elevated levels of DNA base damage [61], 
DNA adducts [62, 63] and DNA strand breaks [64] in sperm of smokers. Studies using FISH 
have also shown that smokers have increased levels of chromosomal defects in their sperm [65-
67]. It is tempting to speculate that daily tobacco smoke may induce accumulation of DNA 
damage in sperm especially during the last two or three weeks before fertilization and that even 
moderate smoking may lead to accumulated detrimental effects on the genetic integrity of the 
fertilizing sperm. 
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We noted that a few of the fertilizing sperm had unusually high levels of chromosomal 
damage (Figure 2B). Data from previous studies from our laboratory using B6C3F1 mice (Figure 
5) showed that this is a common occurrence in male exposures that produced chromosomal 
aberrations in the majority of the zygotes. As shown in Figure 4, zygotes with structural 
aberrations involving 7 or more paternal chromosomes were found only in treatments that 
produced chromosomal aberrations in >45% of the zygotes analyzed. In addition, zygotes with 
highly damaged paternal chromosomal complements represented <10% of the abnormal zygotes. 
However, in the present study, although DEB induced chromosomal aberrations in only 10-15% 
of the zygotes analyzed, zygotes with highly damaged paternal chromosomal complements 
represented  ~30% of the abnormal zygotes. A similar observation was previously reported in 
mouse zygotes after paternal exposure to 26 mg/kg DEB [51] and suggests that there is a 
subpopulation of sperm that is highly susceptible to DEB. We speculate that this subpopulation 
of sperm may have a more relaxed chromatin conformation that allows greater numbers of DNA 
intra- and inter-strand DEB adducts to be formed and hence greater numbers of chromosomal 
aberrations in zygotes. Regardless of the molecular mechanism underlying the exquisite 
sensitivity of this subpopulation of sperm to DEB, our results demonstrate that high levels of 
heritable damage in sperm do not affect fertilization and development during the first cell cycle 
after fertilization. 
 Comparisons of our results with the literature [49, 51], confirm the higher sensitivity of 
postmeiotic male germ cells to DEB as compared to female germ cells. The yield of zygotes with 
chromosomal structural aberrations is at least 3-fold higher after exposing male gametes to DEB 
seven days before mating than after treating female gametes with a similar dose ~2 days before 
mating, which represent treatment of dictyate oocytes [49]. The difference is even higher when 
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the amount of chromosomal damage is considered [49]. Although dictyate oocytes are 
characterized by a diffuse chromatin state that is thought to make them particularly sensitive to 
DNA-interacting chemical agents [68-70], oocytes have fully functional DNA repair 
mechanisms throughout oogenesis and provide gene products that are responsible for repairing 
DNA damage in both parental genomes after fertilization [26, 71, 72]. Therefore, it is likely that 
DNA lesions induced by DEB in oocytes are repaired before fertilization and before pronuclear 
DNA synthesis takes place. Also, after oocyte exposure, chromatid-type breaks and exchanges 
represented half of the aberrations that were observed at zygotic metaphase [49]; in contrast, 
exposure of male germ cells induced almost exclusively chromosome-type aberrations. Because 
chromosome-type aberrations require the presence of a DNA double strand break before DNA 
synthesis begins, these results suggest that DEB-induced sperm DNA lesions produced double 
strand breaks before the oocyte repair machinery had the chance of repairing the original DEB 
lesion, most likely during the profound chromatin reorganization that occurs in the male 
pronucleus immediately after fertilization and before pronuclear S-phase [73]. These findings 
indicate that chromatin organization and, more importantly, DNA repair status in gametes have a 
high impact on both the types and frequencies of chromosomal aberrations generated in zygotes. 
 In conclusions, our results show that late postmeiotic male germ cells are extremely 
susceptible to the accumulation of2 DNA lesions because of diminished DNA repair capacity 
and that these lesions are transmitted to the fertilized egg where they are converted into 
chromosomal aberrations during the first cell cycle after fertilization. Our results also show that 
continuous low dose exposures during the postmeiotic phase of spermatogenesis are as 
detrimental as acute exposures. This has important implications for males in their reproductive 
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years who are exposed to low levels of chemicals because of chronic occupational or life style 
(e.g. tobacco smoking) exposures in the weeks prior to successful fertilization. 
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Table 1 – Chromosomal aberrations in first-cleavage (1-Cl) zygote metaphases after repeated or 
single exposures of male mice to DEB at various times prior to mating with untreated females. 
Exp. Dose No. of Total dose Mating  No. of 1-Cl 1-Cl with aberrations 
No. mg/kg doses mg/kg timea  analyzed No.   % ± S.E.b 
1 0 7 0 0  288 2 0.7 ± 0.3 
2 2 7 14 0  225 5 2.2 ± 1.1g 
3 14 1 14 7  270 5 1.9 ± 1.0g 
4 3 7 21 0  226 20 (4)c 8.8 ± 4.4d 
5 21 1 21 7  288 16 (3)c 5.6 ± 1.0d 
6 28 1 28 7  257 25 (4)c 9.7 ± 2.3d 
7 28 1 28 14  213 9 4.2 ± 0.6e 
8 28 1 28 21  227 3 1.3 ± 0.2 
9 4 7 28 0  323 38 (4)c 11.8 ± 4.5d 
10 4 7 28 7  262 24 9.2 ± 3.2e, f 
11 4 7 28 14  278 3 1.1 ± 0.8 
12 4 14 52 0  294 49 (11)c 16.7 ± 4.1d 
13 4 14 52 7  275 24 8.7 ± 2.7d 
14 4 21 84 0  207 34 (5)c 16.4 ± 1.4d 
aDays between last DEB injection and day of mating. 
bStandard error.  
cZygotes with structural aberrations affecting more than 6 paternal chromosomes. 
dP<0.001 vs. controls (Chi-square). 
eP<0.01 vs. controls (Chi-square). 
fP<0.05 vs. experiment 7 (Chi-square). 
gP>0.14 vs. controls (Chi-square). 
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Figure Legends 
 
Figure 1. Exposure regimens for the 14 experiments of the present study. A schematic of the 
last three weeks of mouse spermatogenesis is shown at the top. Below the schematic, 
the duration of each treatment and the administered daily dose of DEB are given. 
 
Figure 2. Photomicrographs of mouse first-cleavage (1-Cl) zygotes collected after exposing 
male mice to DEB. Analysis of metaphases was done using multicolor FISH painting 
probes with a probe combination that detects ~60% of all chromosomal exchanges.  
With this combination, chromosomes 1, 3, and 5 appear red, chromosomes 2, 4, and 6 
appear green and the sex chromosomes appear yellow.  A. Normal zygote with the Y-
bearing paternal chromosomes on the right. B. Paternal chromosomes with extensive 
damage in a zygote fertilized by a sperm from a male treated with DEB. Examples of 
chromosomal exchanges (arrows) and of acentric fragments (arrowheads) are 
indicated. 
 
Figure 3. Comparison of the frequencies of zygotes with chromosomal aberrations after either 
single or fractionated exposures to DEB. A. For the time-response study, male mice 
were treated with 28 mg/kg DEB either as a single dose or as seven daily doses of 4 
mg/kg and mated with untreated females. The numbers in parentheses refer to the 
experiment numbers of Figure 1. Bars represent the standard error. *P<0.05 vs. single 
exposure. B. For the dose-response study, male mice were treated with 14, 21 or 28 
mg/kg DEB either as single doses seven days before mating or distributed over seven 
days. The numbers in parentheses refer to the experiment numbers of Figure 1. Bars 
represent the standard error. 
 
Figure 4. Three-window model for the sensitivity of spermiogenesis to DEB-induced damage. 
A schema of spermiogenesis is shown with the timing of appearance of transition 
proteins (TP) and protamines (based on Meistrich et al 2003). See Discussion for 
explanation.  
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Figure 5. Comparisons of the distribution of damaged zygotes after paternal DEB exposure 
with other paternal exposure studies. The chemicals are ranked by increasing 
percentages of abnormal zygotes. For DEB, the data from experiments 4, 5, 6, 9, 12 
and 14 were used (182/1595). As the frequencies of zygotes with chromosomal 
aberrations increase so do the proportions of zygotes with more than 2 chromosomal 
aberrations. DEB has a profile that is similar to those produced by exposures that 
generate much higher frequencies of zygotes with chromosomal aberrations. C: 
controls; ET: Etoposide; DEB: diepoxybutane; AA: acrylamide; IR: ionizing 
radiation; CP: cyclophosphamide; MMS: methyl methanesulphonate; MLP: 
melphalan. Data from (41) for acrylamide; (42) for etoposide; and (38) for the other 
chemicals.  
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days 21  14  7 0 
Spermatocytes Total 
Meiosis dose
(mg/kg)
Experiment 1 0
Experiment 2 2 2 2 2 2 2 2 14
Experiment 3 14 14
Experiment 4 3 3 3 3 3 3 3 21
Experiment 5 21 21
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Experiment 8 28 28
Experiment 9 4 4 4 4 4 4 4 28
Experiment 10 4 4 4 4 4 4 4 28
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Experiment 12 4 4 4 4 4 4 4 4 4 4 4 4 4 4 56
Experiment 13 4 4 4 4 4 4 4 4 4 4 4 4 4 4 56
Experiment 14 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 84
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Postmeiosis
SpermSpermatids
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